Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Cerebrovascular Disorders

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 51 articles:
HTML format
Text format



Single Articles


    July 2017
  1. SAKAMOTO R, Higuchi A, Tsuda K, Tanimoto T, et al
    Intensive speech and language therapy after stroke.
    Lancet. 2017;390:228.
    PubMed     Text format    


  2. BREITENSTEIN C, Martus P, Willmes K, Ziegler W, et al
    Intensive speech and language therapy after stroke - Authors' reply.
    Lancet. 2017;390:228-229.
    PubMed     Text format    


  3. ASAKAWA T, Zong L, Wang L, Xia Y, et al
    Unmet challenges for rehabilitation after stroke in China.
    Lancet. 2017;390:121-122.
    PubMed     Text format    


  4. DESIMONE CV, Graff-Radford J, El-Harasis MA, Rabinstein AA, et al
    Cerebral amyloid angiopathy and implications for atrial fibrillation management.
    Lancet. 2017;390:9-11.
    PubMed     Text format    


    June 2017

  5. Family-led rehabilitation after stroke in India (ATTEND): a randomised controlled trial.
    Lancet. 2017 Jun 27. pii: S0140-6736(17)31447.
    PubMed     Text format     Abstract available


  6. SHAKIR R, Norrving B
    Stroke in ICD-11: the end of a long exile.
    Lancet. 2017;389:2373.
    PubMed     Text format    


    April 2017
  7. HACHINSKI V
    Stoop to conquer: preventing stroke and dementia together.
    Lancet. 2017;389:1518.
    PubMed     Text format    


    March 2017
  8. HEALEY JS, Oldgren J
    Risk of mortality and stroke after atrial fibrillation - Authors' reply.
    Lancet. 2017;389:907.
    PubMed     Text format    


  9. HUO Z
    Risk of mortality and stroke after atrial fibrillation.
    Lancet. 2017;389:907.
    PubMed     Text format    


  10. MIHAS C, Mariolis A, Letsas KP, Kantzanou M, et al
    Risk of mortality and stroke after atrial fibrillation.
    Lancet. 2017;389:906.
    PubMed     Text format    


    February 2017
  11. BREITENSTEIN C, Grewe T, Floel A, Ziegler W, et al
    Intensive speech and language therapy in patients with chronic aphasia after stroke: a randomised, open-label, blinded-endpoint, controlled trial in a health-care setting.
    Lancet. 2017 Feb 27. pii: S0140-6736(17)30067.
    PubMed     Text format     Abstract available


    January 2017
  12. MORITA T, Higuchi A, Ozaki A, Shimada Y, et al
    The possibility of vascular care for prevention of dementia.
    Lancet. 2017;389:152-153.
    PubMed     Text format    


  13. HANLEY DF, Lane K, McBee N, Ziai W, et al
    Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial.
    Lancet. 2017 Jan 9. pii: S0140-6736(16)32410.
    PubMed     Text format     Abstract available


  14. RABINSTEIN AA
    Intracerebral haemorrhage: no good treatment but treatment helps.
    Lancet. 2017 Jan 9. pii: S0140-6736(17)30002.
    PubMed     Text format    


  15. O'DONNELL M, Yusuf S
    The INTERSTROKE study on risk factors for stroke - Authors' reply.
    Lancet. 2017;389:36.
    PubMed     Text format    


  16. MERCHANT AT
    The INTERSTROKE study on risk factors for stroke.
    Lancet. 2017;389:35-36.
    PubMed     Text format    


  17. ZENG X, Deng A, Ding Y
    The INTERSTROKE study on risk factors for stroke.
    Lancet. 2017;389:35.
    PubMed     Text format    


    November 2016
  18. COLLINS R, Reith C, Emberson J, Armitage J, et al
    Interpretation of the evidence for the efficacy and safety of statin therapy.
    Lancet. 2016;388:2532-2561.
    PubMed     Text format     Abstract available


    October 2016
  19. MAKIKALLIO T, Holm NR, Lindsay M, Spence MS, et al
    Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial.
    Lancet. 2016 Oct 28. pii: S0140-6736(16)32052.
    PubMed     Text format     Abstract available


  20. CHARIDIMOU A
    The ABC risk score for patients with atrial fibrillation.
    Lancet. 2016;388:1979.
    PubMed     Text format    


  21. PROVIDENCIA R, Lambiase PD
    The ABC risk score for patients with atrial fibrillation.
    Lancet. 2016;388:1979-1980.
    PubMed     Text format    


  22. GUAN WJ, Zheng XY, Chung KF, Zhong NS, et al
    Impact of air pollution on the burden of chronic respiratory diseases in China: time for urgent action.
    Lancet. 2016;388:1939-1951.
    PubMed     Text format     Abstract available


  23. SHAKIR R, Davis S, Norrving B, Grisold W, et al
    Revising the ICD: stroke is a brain disease.
    Lancet. 2016 Oct 14. pii: S0140-6736(16)31850.
    PubMed     Text format    


  24. LEUNG DY, Wong EM, Chan AW, Zhao Y, et al
    Associations between body-mass index and second-hand smoke exposure and stroke recurrence in Chinese patients in Xi'an, Shantou, and Chongqing: a multicentre cross-sectional survey.
    Lancet. 2016;388 Suppl 1:S50.
    PubMed     Text format     Abstract available


    September 2016
  25. HANKEY GJ
    Stroke.
    Lancet. 2016 Sep 13. pii: S0140-6736(16)30962.
    PubMed     Text format     Abstract available


    August 2016
  26. GOETTE A, Merino JL, Ezekowitz MD, Zamoryakhin D, et al
    Edoxaban versus enoxaparin-warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial.
    Lancet. 2016 Aug 26. pii: S0140-6736(16)31474.
    PubMed     Text format     Abstract available


  27. VIDAL-PETIOT E, Ford I, Greenlaw N, Ferrari R, et al
    Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study.
    Lancet. 2016 Aug 26. pii: S0140-6736(16)31326.
    PubMed     Text format     Abstract available


  28. FREEDMAN B, Potpara TS, Lip GY
    Stroke prevention in atrial fibrillation.
    Lancet. 2016;388:806-817.
    PubMed     Text format     Abstract available


  29. BAGOT KL, Cadilhac DA, Hand PJ, Vu M, et al
    Telemedicine expedites access to optimal acute stroke care.
    Lancet. 2016;388:757-758.
    PubMed     Text format    


  30. THE LANCET
    Atrial fibrillation and stroke: unrecognised and undertreated.
    Lancet. 2016;388:731.
    PubMed     Text format    


  31. PICCINI JP, Fauchier L
    Rhythm control in atrial fibrillation.
    Lancet. 2016;388:829-840.
    PubMed     Text format     Abstract available


  32. MOLL VAN CHARANTE EP, Richard E, Eurelings LS, van Dalen JW, et al
    Effectiveness of a 6-year multidomain vascular care intervention to prevent dementia (preDIVA): a cluster-randomised controlled trial.
    Lancet. 2016;388:797-805.
    PubMed     Text format     Abstract available


  33. LARSEN TB, Nielsen PB
    Stroke and mortality after atrial fibrillation-a global struggle.
    Lancet. 2016 Aug 8. pii: S0140-6736(16)31274.
    PubMed     Text format    


  34. HEALEY JS, Oldgren J, Ezekowitz M, Zhu J, et al
    Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study.
    Lancet. 2016 Aug 8. pii: S0140-6736(16)30968.
    PubMed     Text format     Abstract available


  35. BORLONGAN CV
    Age of PISCES: stem-cell clinical trials in stroke.
    Lancet. 2016 Aug 3. pii: S0140-6736(16)31259.
    PubMed     Text format    


  36. KALLADKA D, Sinden J, Pollock K, Haig C, et al
    Human neural stem cells in patients with chronic ischaemic stroke (PISCES): a phase 1, first-in-man study.
    Lancet. 2016 Aug 3. pii: S0140-6736(16)30513.
    PubMed     Text format     Abstract available


    July 2016
  37. SNYDER A
    Philip Majerus.
    Lancet. 2016;388:458.
    PubMed     Text format    


  38. FEIGIN VL, Krishnamurthi R
    Stroke is largely preventable across the globe: where to next?
    Lancet. 2016 Jul 15. pii: S0140-6736(16)30679.
    PubMed     Text format    


  39. O'DONNELL MJ, Chin SL, Rangarajan S, Xavier D, et al
    Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study.
    Lancet. 2016 Jul 15. pii: S0140-6736(16)30506.
    PubMed     Text format     Abstract available


  40. BLACK N
    Is hospital mortality higher at weekends? If so, why?
    Lancet. 2016;388:108-11.
    PubMed     Text format    


    May 2016
  41. KAUFMAN JD, Adar SD, Barr RG, Budoff M, et al
    Association between air pollution and coronary artery calcification within six metropolitan areas in the USA (the Multi-Ethnic Study of Atherosclerosis and Air Pollution): a longitudinal cohort study.
    Lancet. 2016 May 24. pii: S0140-6736(16)00378.
    PubMed     Text format     Abstract available


  42. ROTHWELL PM, Algra A, Chen Z, Diener HC, et al
    Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials.
    Lancet. 2016 May 18. pii: S0140-6736(16)30468.
    PubMed     Text format     Abstract available


  43. HANKEY GJ
    The benefits of aspirin in early secondary stroke prevention.
    Lancet. 2016 May 18. pii: S0140-6736(16)30511.
    PubMed     Text format    


  44. BRAY BD, Cloud GC, James MA, Hemingway H, et al
    Weekly variation in health-care quality by day and time of admission: a nationwide, registry-based, prospective cohort study of acute stroke care.
    Lancet. 2016 May 10. pii: S0140-6736(16)30443.
    PubMed     Text format     Abstract available


  45. PRODAN CI
    Platelets after intracerebral haemorrhage: more is not better.
    Lancet. 2016 May 9. pii: S0140-6736(16)30478.
    PubMed     Text format    


  46. BAHAROGLU MI, Cordonnier C, Salman RA, de Gans K, et al
    Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial.
    Lancet. 2016 May 9. pii: S0140-6736(16)30392.
    PubMed     Text format     Abstract available


  47. SANDERCOCK P, Wardlaw J, Lindley R, Whiteley W, et al
    IST-3 stroke trial data available.
    Lancet. 2016;387:1904.
    PubMed     Text format    


  48. GUILLEVIN L, Regent A
    Treating giant-cell arteritis: is IL-6 the cytokine to target?
    Lancet. 2016;387:1882-1883.
    PubMed     Text format    


    April 2016
  49. HIJAZI Z, Oldgren J, Lindback J, Alexander JH, et al
    The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study.
    Lancet. 2016 Apr 1. pii: S0140-6736(16)00741.
    PubMed     Text format     Abstract available


    March 2016
  50. VILLIGER PM, Adler S, Kuchen S, Wermelinger F, et al
    Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial.
    Lancet. 2016 Mar 4. pii: S0140-6736(16)00560.
    PubMed     Text format     Abstract available


    February 2016
  51. BLACHER J, Levy BI, Mourad JJ, Safar ME, et al
    From epidemiological transition to modern cardiovascular epidemiology: hypertension in the 21st century.
    Lancet. 2016 Feb 5. pii: S0140-6736(16)00002.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Cerebrovascular Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: